Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:41 PM
Ignite Modification Date:
2025-12-24 @ 9:41 PM
NCT ID:
NCT03244332
Eligibility Criteria:
Inclusion Criteria:
* Children suffering from decompensated cirrhosis and needing an orthotopic liver transplantation
* Children suffering from a compensated cirrhosis (compensated cirrhosis with kasai surgery in biliary atresia patients e.g) or from portal hypertension without cirrhosis (portal vein thrombosis e.g)
* Each patient will have a comprehensive assessment of portal hypertension (abdominal US-Doppler and upper gastrointestinal endoscopy) and hemostasis
Exclusion Criteria:
* No underlying disease which can alter hemostasis (hemophilia, sepsis…)
* No medication which can alter hemostasis (aspirin, anti-inflammatory drugs,…)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
4 Months
Maximum Age:
50 Years
Study:
NCT03244332
Study Brief:
Protocol Section:
NCT03244332